nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxsalen—CYP1A2—Carmustine—lymphatic system cancer	0.308	0.471	CbGbCtD
Methoxsalen—CYP3A4—Cytarabine—lymphatic system cancer	0.11	0.168	CbGbCtD
Methoxsalen—CYP3A4—Teniposide—lymphatic system cancer	0.108	0.166	CbGbCtD
Methoxsalen—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0758	0.116	CbGbCtD
Methoxsalen—CYP3A4—Vincristine—lymphatic system cancer	0.0521	0.0797	CbGbCtD
Methoxsalen—Pain of skin—Bleomycin—lymphatic system cancer	0.0225	0.0651	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Mechlorethamine—lymphatic system cancer	0.0188	0.0543	CcSEcCtD
Methoxsalen—Blister—Mechlorethamine—lymphatic system cancer	0.0155	0.0448	CcSEcCtD
Methoxsalen—Digestion impaired—Fludarabine—lymphatic system cancer	0.0108	0.0313	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Bleomycin—lymphatic system cancer	0.00892	0.0258	CcSEcCtD
Methoxsalen—Dermatitis bullous—Mechlorethamine—lymphatic system cancer	0.00848	0.0245	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Carmustine—lymphatic system cancer	0.00779	0.0225	CcSEcCtD
Methoxsalen—Sunburn—Methotrexate—lymphatic system cancer	0.0071	0.0205	CcSEcCtD
Methoxsalen—Depression—Mechlorethamine—lymphatic system cancer	0.00623	0.018	CcSEcCtD
Methoxsalen—Tenderness—Bleomycin—lymphatic system cancer	0.00608	0.0176	CcSEcCtD
Methoxsalen—Skin exfoliation—Bleomycin—lymphatic system cancer	0.00507	0.0146	CcSEcCtD
Methoxsalen—Leukoderma—Methotrexate—lymphatic system cancer	0.00505	0.0146	CcSEcCtD
Methoxsalen—Skin exfoliation—Carmustine—lymphatic system cancer	0.00442	0.0128	CcSEcCtD
Methoxsalen—Vertigo—Mechlorethamine—lymphatic system cancer	0.00439	0.0127	CcSEcCtD
Methoxsalen—Infection—Mechlorethamine—lymphatic system cancer	0.00396	0.0114	CcSEcCtD
Methoxsalen—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00387	0.0112	CcSEcCtD
Methoxsalen—Arrhythmia—Teniposide—lymphatic system cancer	0.00369	0.0107	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Methotrexate—lymphatic system cancer	0.00361	0.0104	CcSEcCtD
Methoxsalen—Folliculitis—Methotrexate—lymphatic system cancer	0.00341	0.00986	CcSEcCtD
Methoxsalen—Arrhythmia—Fludarabine—lymphatic system cancer	0.00325	0.00938	CcSEcCtD
Methoxsalen—Oedema—Teniposide—lymphatic system cancer	0.00294	0.00849	CcSEcCtD
Methoxsalen—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00294	0.00848	CcSEcCtD
Methoxsalen—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00294	0.00848	CcSEcCtD
Methoxsalen—Infection—Teniposide—lymphatic system cancer	0.00292	0.00843	CcSEcCtD
Methoxsalen—Malaise—Fludarabine—lymphatic system cancer	0.00285	0.00824	CcSEcCtD
Methoxsalen—Pruritus—Mechlorethamine—lymphatic system cancer	0.00282	0.00815	CcSEcCtD
Methoxsalen—Hypotension—Teniposide—lymphatic system cancer	0.00275	0.00793	CcSEcCtD
Methoxsalen—Discomfort—Fludarabine—lymphatic system cancer	0.00266	0.00769	CcSEcCtD
Methoxsalen—Depression—Carmustine—lymphatic system cancer	0.00258	0.00747	CcSEcCtD
Methoxsalen—Oedema—Fludarabine—lymphatic system cancer	0.00258	0.00746	CcSEcCtD
Methoxsalen—Infection—Fludarabine—lymphatic system cancer	0.00257	0.00741	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00253	0.00732	CcSEcCtD
Methoxsalen—Rash—Mechlorethamine—lymphatic system cancer	0.00251	0.00726	CcSEcCtD
Methoxsalen—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00251	0.00725	CcSEcCtD
Methoxsalen—Depression—Vincristine—lymphatic system cancer	0.00247	0.00713	CcSEcCtD
Methoxsalen—Feeling abnormal—Teniposide—lymphatic system cancer	0.00242	0.007	CcSEcCtD
Methoxsalen—Nausea—Mechlorethamine—lymphatic system cancer	0.00237	0.00684	CcSEcCtD
Methoxsalen—Urticaria—Teniposide—lymphatic system cancer	0.00233	0.00674	CcSEcCtD
Methoxsalen—Herpes simplex—Methotrexate—lymphatic system cancer	0.00233	0.00673	CcSEcCtD
Methoxsalen—Body temperature increased—Teniposide—lymphatic system cancer	0.00232	0.00671	CcSEcCtD
Methoxsalen—Erythema—Bleomycin—lymphatic system cancer	0.00232	0.0067	CcSEcCtD
Methoxsalen—Dyspepsia—Fludarabine—lymphatic system cancer	0.00227	0.00657	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00223	0.00644	CcSEcCtD
Methoxsalen—Inflammation—Methotrexate—lymphatic system cancer	0.00221	0.00639	CcSEcCtD
Methoxsalen—Hypersensitivity—Teniposide—lymphatic system cancer	0.00216	0.00625	CcSEcCtD
Methoxsalen—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00215	0.00622	CcSEcCtD
Methoxsalen—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00213	0.00615	CcSEcCtD
Methoxsalen—Malaise—Bleomycin—lymphatic system cancer	0.00209	0.00604	CcSEcCtD
Methoxsalen—Pruritus—Teniposide—lymphatic system cancer	0.00208	0.00601	CcSEcCtD
Methoxsalen—Arrhythmia—Carmustine—lymphatic system cancer	0.00208	0.006	CcSEcCtD
Methoxsalen—Skin exfoliation—Methotrexate—lymphatic system cancer	0.00205	0.00592	CcSEcCtD
Methoxsalen—Body temperature increased—Fludarabine—lymphatic system cancer	0.00204	0.0059	CcSEcCtD
Methoxsalen—Erythema—Carmustine—lymphatic system cancer	0.00202	0.00585	CcSEcCtD
Methoxsalen—Discomfort—Bleomycin—lymphatic system cancer	0.00195	0.00564	CcSEcCtD
Methoxsalen—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00193	0.00558	CcSEcCtD
Methoxsalen—Hypersensitivity—Fludarabine—lymphatic system cancer	0.0019	0.0055	CcSEcCtD
Methoxsalen—Oedema—Bleomycin—lymphatic system cancer	0.00189	0.00547	CcSEcCtD
Methoxsalen—Erythema—Mitoxantrone—lymphatic system cancer	0.00188	0.00544	CcSEcCtD
Methoxsalen—Infection—Bleomycin—lymphatic system cancer	0.00188	0.00543	CcSEcCtD
Methoxsalen—Rash—Teniposide—lymphatic system cancer	0.00185	0.00535	CcSEcCtD
Methoxsalen—Dermatitis—Teniposide—lymphatic system cancer	0.00185	0.00535	CcSEcCtD
Methoxsalen—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00184	0.00533	CcSEcCtD
Methoxsalen—Headache—Teniposide—lymphatic system cancer	0.00184	0.00532	CcSEcCtD
Methoxsalen—Pruritus—Fludarabine—lymphatic system cancer	0.00183	0.00528	CcSEcCtD
Methoxsalen—Hypotension—Bleomycin—lymphatic system cancer	0.00177	0.00511	CcSEcCtD
Methoxsalen—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00175	0.00505	CcSEcCtD
Methoxsalen—Nausea—Teniposide—lymphatic system cancer	0.00175	0.00504	CcSEcCtD
Methoxsalen—Vertigo—Vincristine—lymphatic system cancer	0.00174	0.00502	CcSEcCtD
Methoxsalen—Malaise—Mitoxantrone—lymphatic system cancer	0.0017	0.00491	CcSEcCtD
Methoxsalen—Oedema—Carmustine—lymphatic system cancer	0.00165	0.00478	CcSEcCtD
Methoxsalen—Infection—Carmustine—lymphatic system cancer	0.00164	0.00474	CcSEcCtD
Methoxsalen—Rash—Fludarabine—lymphatic system cancer	0.00163	0.0047	CcSEcCtD
Methoxsalen—Dermatitis—Fludarabine—lymphatic system cancer	0.00163	0.0047	CcSEcCtD
Methoxsalen—Headache—Fludarabine—lymphatic system cancer	0.00162	0.00467	CcSEcCtD
Methoxsalen—Discomfort—Mitoxantrone—lymphatic system cancer	0.00158	0.00458	CcSEcCtD
Methoxsalen—Oedema—Vincristine—lymphatic system cancer	0.00158	0.00456	CcSEcCtD
Methoxsalen—Infection—Vincristine—lymphatic system cancer	0.00157	0.00453	CcSEcCtD
Methoxsalen—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00156	0.00451	CcSEcCtD
Methoxsalen—Hypotension—Carmustine—lymphatic system cancer	0.00154	0.00446	CcSEcCtD
Methoxsalen—Oedema—Mitoxantrone—lymphatic system cancer	0.00154	0.00444	CcSEcCtD
Methoxsalen—Nausea—Fludarabine—lymphatic system cancer	0.00153	0.00443	CcSEcCtD
Methoxsalen—Infection—Mitoxantrone—lymphatic system cancer	0.00153	0.00441	CcSEcCtD
Methoxsalen—Urticaria—Bleomycin—lymphatic system cancer	0.0015	0.00435	CcSEcCtD
Methoxsalen—Body temperature increased—Bleomycin—lymphatic system cancer	0.0015	0.00432	CcSEcCtD
Methoxsalen—Insomnia—Carmustine—lymphatic system cancer	0.00149	0.00432	CcSEcCtD
Methoxsalen—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00149	0.00431	CcSEcCtD
Methoxsalen—Hypotension—Vincristine—lymphatic system cancer	0.00147	0.00426	CcSEcCtD
Methoxsalen—Hypotension—Mitoxantrone—lymphatic system cancer	0.00144	0.00415	CcSEcCtD
Methoxsalen—Insomnia—Vincristine—lymphatic system cancer	0.00143	0.00412	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00143	0.00412	CcSEcCtD
Methoxsalen—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00139	0.00403	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00136	0.00394	CcSEcCtD
Methoxsalen—Feeling abnormal—Carmustine—lymphatic system cancer	0.00136	0.00393	CcSEcCtD
Methoxsalen—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00135	0.00391	CcSEcCtD
Methoxsalen—Pruritus—Bleomycin—lymphatic system cancer	0.00134	0.00387	CcSEcCtD
Methoxsalen—Body temperature increased—Carmustine—lymphatic system cancer	0.00131	0.00377	CcSEcCtD
Methoxsalen—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00127	0.00366	CcSEcCtD
Methoxsalen—Body temperature increased—Vincristine—lymphatic system cancer	0.00125	0.0036	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00123	0.00355	CcSEcCtD
Methoxsalen—Urticaria—Mitoxantrone—lymphatic system cancer	0.00122	0.00353	CcSEcCtD
Methoxsalen—Hypersensitivity—Carmustine—lymphatic system cancer	0.00122	0.00352	CcSEcCtD
Methoxsalen—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00121	0.00351	CcSEcCtD
Methoxsalen—Depression—Methotrexate—lymphatic system cancer	0.0012	0.00346	CcSEcCtD
Methoxsalen—Rash—Bleomycin—lymphatic system cancer	0.00119	0.00345	CcSEcCtD
Methoxsalen—Dermatitis—Bleomycin—lymphatic system cancer	0.00119	0.00345	CcSEcCtD
Methoxsalen—Hypersensitivity—Vincristine—lymphatic system cancer	0.00116	0.00336	CcSEcCtD
Methoxsalen—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00113	0.00327	CcSEcCtD
Methoxsalen—Nausea—Bleomycin—lymphatic system cancer	0.00112	0.00325	CcSEcCtD
Methoxsalen—Dizziness—Carmustine—lymphatic system cancer	0.00109	0.00316	CcSEcCtD
Methoxsalen—Dizziness—Vincristine—lymphatic system cancer	0.00104	0.00301	CcSEcCtD
Methoxsalen—Rash—Carmustine—lymphatic system cancer	0.00104	0.00301	CcSEcCtD
Methoxsalen—Dermatitis—Carmustine—lymphatic system cancer	0.00104	0.00301	CcSEcCtD
Methoxsalen—Headache—Carmustine—lymphatic system cancer	0.00104	0.00299	CcSEcCtD
Methoxsalen—Rash—Vincristine—lymphatic system cancer	0.000995	0.00287	CcSEcCtD
Methoxsalen—Dermatitis—Vincristine—lymphatic system cancer	0.000994	0.00287	CcSEcCtD
Methoxsalen—Headache—Vincristine—lymphatic system cancer	0.000988	0.00286	CcSEcCtD
Methoxsalen—Nausea—Carmustine—lymphatic system cancer	0.000982	0.00284	CcSEcCtD
Methoxsalen—Rash—Mitoxantrone—lymphatic system cancer	0.000969	0.0028	CcSEcCtD
Methoxsalen—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000968	0.0028	CcSEcCtD
Methoxsalen—Headache—Mitoxantrone—lymphatic system cancer	0.000962	0.00278	CcSEcCtD
Methoxsalen—Erythema—Methotrexate—lymphatic system cancer	0.000938	0.00271	CcSEcCtD
Methoxsalen—Nausea—Vincristine—lymphatic system cancer	0.000937	0.00271	CcSEcCtD
Methoxsalen—Dysgeusia—Methotrexate—lymphatic system cancer	0.000918	0.00265	CcSEcCtD
Methoxsalen—Nausea—Mitoxantrone—lymphatic system cancer	0.000913	0.00264	CcSEcCtD
Methoxsalen—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00087	0.00251	CcSEcCtD
Methoxsalen—Malaise—Methotrexate—lymphatic system cancer	0.000846	0.00244	CcSEcCtD
Methoxsalen—Vertigo—Methotrexate—lymphatic system cancer	0.000843	0.00243	CcSEcCtD
Methoxsalen—Discomfort—Methotrexate—lymphatic system cancer	0.000789	0.00228	CcSEcCtD
Methoxsalen—Infection—Methotrexate—lymphatic system cancer	0.00076	0.0022	CcSEcCtD
Methoxsalen—Skin disorder—Methotrexate—lymphatic system cancer	0.000743	0.00215	CcSEcCtD
Methoxsalen—Hypotension—Methotrexate—lymphatic system cancer	0.000715	0.00207	CcSEcCtD
Methoxsalen—Insomnia—Methotrexate—lymphatic system cancer	0.000692	0.002	CcSEcCtD
Methoxsalen—Dyspepsia—Methotrexate—lymphatic system cancer	0.000674	0.00195	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000661	0.00191	CcSEcCtD
Methoxsalen—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000631	0.00182	CcSEcCtD
Methoxsalen—Urticaria—Methotrexate—lymphatic system cancer	0.000608	0.00176	CcSEcCtD
Methoxsalen—Body temperature increased—Methotrexate—lymphatic system cancer	0.000605	0.00175	CcSEcCtD
Methoxsalen—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000564	0.00163	CcSEcCtD
Methoxsalen—Pruritus—Methotrexate—lymphatic system cancer	0.000542	0.00156	CcSEcCtD
Methoxsalen—Dizziness—Methotrexate—lymphatic system cancer	0.000506	0.00146	CcSEcCtD
Methoxsalen—Rash—Methotrexate—lymphatic system cancer	0.000483	0.00139	CcSEcCtD
Methoxsalen—Dermatitis—Methotrexate—lymphatic system cancer	0.000482	0.00139	CcSEcCtD
Methoxsalen—Headache—Methotrexate—lymphatic system cancer	0.00048	0.00139	CcSEcCtD
Methoxsalen—Nausea—Methotrexate—lymphatic system cancer	0.000455	0.00131	CcSEcCtD
